Top Three Regenerative Medicine Companies Targeting Ischemic Conditions
As we discussed in our first article on elite regenerative medicine companies, there are several methodologies to delineating the “cream of the crop.” In this exercise, we will take a look at the impact that regenerative medicine technologies can have on ischemic conditions – where tissue in[...]
Featured Stories
- Athersys Recognized in Peer-Reviewed Journals as Stock Maintains Strong Upward Move
- Retrace and Rise, Athersys Back on the Move
- Rejuvenated Regenerative Medicine: Stem Cells and Athersys on the Rise
- Athersys (ATHX) Jumps 55% YTD Amid Growing Investor Interest
- Top Three Regenerative Medicine Companies Targeting Ischemic Conditions
Other News
- Neuralstem And The National Football League Alumni Association Announce Initiative On Brain Injury Treatment
- InVivo Therapeutics Receives Humanitarian Use Device Designation for Spinal Cord Injury Treatment
- Aastrom Biosciences Announces Strategic Change in Research and Development Programs
- Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
- International Stem Cell Corporation Announces Positive Results of Primate Parkinson’s Study
